UA63003U - Способ получения антигенного ешерихиозного эритроцитарного диагностикума - Google Patents
Способ получения антигенного ешерихиозного эритроцитарного диагностикума Download PDFInfo
- Publication number
- UA63003U UA63003U UAU201102056U UAU201102056U UA63003U UA 63003 U UA63003 U UA 63003U UA U201102056 U UAU201102056 U UA U201102056U UA U201102056 U UAU201102056 U UA U201102056U UA 63003 U UA63003 U UA 63003U
- Authority
- UA
- Ukraine
- Prior art keywords
- antigenic
- antigen
- erythrocytes
- production
- diagnosticum
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title abstract description 9
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- 239000000427 antigen Substances 0.000 abstract description 24
- 102000036639 antigens Human genes 0.000 abstract description 24
- 108091007433 antigens Proteins 0.000 abstract description 24
- 210000003743 erythrocyte Anatomy 0.000 abstract description 24
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 11
- 229920001184 polypeptide Polymers 0.000 abstract description 9
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 6
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract description 5
- 235000011130 ammonium sulphate Nutrition 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 abstract description 5
- 241000588722 Escherichia Species 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 4
- 230000001235 sensitizing effect Effects 0.000 abstract description 2
- 239000000725 suspension Substances 0.000 abstract description 2
- 241001494479 Pecora Species 0.000 abstract 1
- 229940036998 hypertonic sodium chloride Drugs 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 235000010469 Glycine max Nutrition 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000013049 sediment Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000008366 buffered solution Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000000405 serological effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000010227 enterocolitis Diseases 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 201000009019 intestinal benign neoplasm Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000033 toxigenic Toxicity 0.000 description 1
- 230000001551 toxigenic effect Effects 0.000 description 1
- 229940066528 trichloroacetate Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Способ получения антигенного ешерихиозного эритроцитарного диагностикума заключается в эстракции антигенов эшерихий, их инактивации, сенсибилизации эритроцитов и приготовлении диагностикума. Изготавливают суспензию энтероинвазивного, високотоксигенного штамма кишечной палочки 0151 "Крым". Осуществляют дезинтеграцию клеток, антиген экстрагируют в виде полипептидного комплекса гипертоническим раствором хлористого натрия, осаждают сульфатом аммония. Эритроциты барана сенсибилизировали формалином и нагружали антигеном.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201102056U UA63003U (ru) | 2011-02-21 | 2011-02-21 | Способ получения антигенного ешерихиозного эритроцитарного диагностикума |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201102056U UA63003U (ru) | 2011-02-21 | 2011-02-21 | Способ получения антигенного ешерихиозного эритроцитарного диагностикума |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA63003U true UA63003U (ru) | 2011-09-26 |
Family
ID=50837649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201102056U UA63003U (ru) | 2011-02-21 | 2011-02-21 | Способ получения антигенного ешерихиозного эритроцитарного диагностикума |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA63003U (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2685413C1 (ru) * | 2018-04-13 | 2019-04-18 | Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский и технологический институт биологической промышленности | Способ изготовления эритроцитарного диагностикума для диагностики поллуроза-тифа птиц |
-
2011
- 2011-02-21 UA UAU201102056U patent/UA63003U/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2685413C1 (ru) * | 2018-04-13 | 2019-04-18 | Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский и технологический институт биологической промышленности | Способ изготовления эритроцитарного диагностикума для диагностики поллуроза-тифа птиц |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tola et al. | Experimental vaccination against Mycoplasma agalactiae using different inactivated vaccines | |
| Barbuddhe et al. | Isolation of Listeria monocytogenes and anti-listeriolysin O detection in sheep and goats | |
| Moura-Costa et al. | Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis | |
| Blouin et al. | Antibodies to Anaplasma marginale major surface proteins 1a and 1b inhibit infectivity for cultured tick cells | |
| CN104258386B (zh) | 一种水貂病毒性肠炎灭活疫苗-犬瘟热活疫苗组合 | |
| Aoki et al. | Stationary phase culture supernatant containing membrane vesicles induced immunity to rainbow trout Oncorhynchus mykiss fry syndrome | |
| CN105530954A (zh) | 鼻粘膜疫苗组合物 | |
| Miles et al. | Linking murine resistance to secondary cystic echinococcosis with antibody responses targeting Echinococcus granulosus tegumental antigens | |
| CN103421832A (zh) | 包含氟苯尼考耐药基因蛋白的卵黄抗体及制备与应用 | |
| Byvalov et al. | Study of Yersinia pseudotuberculosis surface antigen epitopes using monoclonal antibodies | |
| UA63003U (ru) | Способ получения антигенного ешерихиозного эритроцитарного диагностикума | |
| NL8104979A (nl) | Werkwijze voor de bereiding van immunobiologische preparaten, toe te passen bij de diagnose , het voorkomen en/of het behandelen van candida guilliermondii infecties. | |
| CN115887631A (zh) | 一种副猪嗜血杆菌和猪链球菌二联疫苗 | |
| RU2341288C1 (ru) | СРЕДСТВО, ОБЛАДАЮЩЕЕ СВОЙСТВОМ ФОРМИРОВАТЬ КЛЕТОЧНЫЙ ИММУНИТЕТ ПРОТИВ MYCOBACTERIUM TUBERCULOSIS H37 Rv, СПОСОБ ПОЛУЧЕНИЯ ЕГО (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ ШТАММ И СРЕДСТВО ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА | |
| RO129645A0 (ro) | Procedeu de obţinere şi utilizare a imunoglobulinelor de găină () | |
| Acevedo-Monroy et al. | Polyvalent Bacterial Lysate with Potential Use to Treatment and Control of Recurrent Urinary Tract Infections | |
| RU2601158C1 (ru) | ШТАММЫ ВИДА Streptococcus pneumoniae (ВАРИАНТЫ) И СПОСОБ ПОЛУЧЕНИЯ ИЗ НИХ ПРОТЕКТИВНОЙ БЕЛОКСОДЕРЖАЩЕЙ ФРАКЦИИ, ОБЛАДАЮЩЕЙ ВНУТРИВИДОВОЙ ИММУНОГЕННОЙ АКТИВНОСТЬЮ | |
| Rakib et al. | Development of anti-Aeromonas hydrophila serum from rabbits | |
| RU2798283C1 (ru) | Штамм Chlamydia abortus "Chlamydia VNITIBP-21" для производства иммунобиологических лекарственных препаратов | |
| JP7021283B2 (ja) | 魚類の連鎖球菌病予防用新規血清型ワクチン | |
| RU2521651C1 (ru) | ШТАММ БАКТЕРИЙ, Moraxella bovoculi "СХ-Ч6 N-ДЕП" ИСПОЛЬЗУЕМЫЙ ДЛЯ ИЗГОТОВЛЕНИЯ ДИАГНОСТИКУМОВ И ВАКЦИН ПРОТИВ ИНФЕКЦИОННОГО КЕРАТОКОНЪЮКТИВИТА КРУПНОГО РОГАТОГО СКОТА | |
| RU2802251C1 (ru) | Вакцинная композиция для профилактики энзоотического аборта у овец | |
| RU2805871C1 (ru) | Способ получения диагностикума эритроцитарного сибиреязвенного антигенного сухого | |
| Parija | Rickettsia, Orientia, Ehrlichia and Coxiella | |
| Roe et al. | Passive immunization of mice against Klebsiella aerogenes. |